Lamdong Pharmaceutical JSC

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000LDP3
VND
11,700.00
-200 (-1.68%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

VND Million (Micro Cap)

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.38

stock-summary
Return on Equity

8.12%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
50,026 Million
(Quarterly Results - Jun 2025)
Net Profit:
1,225 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.1%
0%
-4.1%
6 Months
5.41%
0%
5.41%
1 Year
3.54%
0%
3.54%
2 Years
-17.02%
0%
-17.02%
3 Years
112.73%
0%
112.73%
4 Years
-68.46%
0%
-68.46%
5 Years
-6.4%
0%
-6.4%

Lamdong Pharmaceutical JSC for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-2.40%
EBIT Growth (5y)
22.02%
EBIT to Interest (avg)
-2.30
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.43
Sales to Capital Employed (avg)
1.25
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.91%
ROE (avg)
6.47%
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
3.33
EV to EBITDA
2.20
EV to Capital Employed
0.27
EV to Sales
0.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
8.20%
ROE (Latest)
6.75%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -17.86% vs -15.16% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 20.76% vs -66.42% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "50,026.30",
          "val2": "60,900.60",
          "chgp": "-17.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,327.40",
          "val2": "4,131.50",
          "chgp": "-43.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "555.60",
          "val2": "2,038.10",
          "chgp": "-72.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,225.00",
          "val2": "1,014.40",
          "chgp": "20.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.60%",
          "val2": "43.30%",
          "chgp": "-2.47%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 17.18% vs -0.75% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 134.41% vs 48.33% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "217,957.80",
          "val2": "186,000.70",
          "chgp": "17.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "20,135.00",
          "val2": "-4,218.70",
          "chgp": "577.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4,978.60",
          "val2": "7,026.60",
          "chgp": "-29.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6,919.00",
          "val2": "-20,104.90",
          "chgp": "134.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "60.90%",
          "val2": "-66.40%",
          "chgp": "12.73%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
50,026.30
60,900.60
-17.86%
Operating Profit (PBDIT) excl Other Income
2,327.40
4,131.50
-43.67%
Interest
555.60
2,038.10
-72.74%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,225.00
1,014.40
20.76%
Operating Profit Margin (Excl OI)
18.60%
43.30%
-2.47%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -17.86% vs -15.16% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 20.76% vs -66.42% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
217,957.80
186,000.70
17.18%
Operating Profit (PBDIT) excl Other Income
20,135.00
-4,218.70
577.28%
Interest
4,978.60
7,026.60
-29.15%
Exceptional Items
0.00
0.00
Consolidate Net Profit
6,919.00
-20,104.90
134.41%
Operating Profit Margin (Excl OI)
60.90%
-66.40%
12.73%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 17.18% vs -0.75% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 134.41% vs 48.33% in Dec 2023

stock-summaryCompany CV
About Lamdong Pharmaceutical JSC stock-summary
stock-summary
Lamdong Pharmaceutical JSC
Pharmaceuticals & Biotechnology
Lamdong Pharmaceutical Joint Stock Company (Ladophar) is a Vietnam-based company engaged in the pharmaceutical industry. The Company is involved in the manufacturing and wholesale trading of pharmaceutical products, as well as functional food, alcoholic and non-alcoholic beverages, including tea and soft drinks. It also imports and exports materials for drug manufacturing activities, along with other medical equipment and supplies. In addition, the Company operates a hotel in Da Lat City, Lam Dong Province. The Company's revenue is derived from four segments: Dalat office and other provinces, drug store system in Lam Dong Province, Hochiminh City branch and Hanoi branch.
Company Coordinates stock-summary
Company Details
So 18 Ngo Quyen, Phuong 6 , DA LAT None : None
stock-summary
Tel: 84 26 3383202084 263 3817937
stock-summary
Registrar Details